myAbbVieCare

Medical

Only for iPhone

Free

iPhone

This app is part of an AbbVie patient support programme intended for patients residing outside of the 48 contiguous United States, Hawaii, and Alaska, for all other US-based patients, please consult your Healthcare Provider for locally available Patient Support Programs. It aims to help you partner with your healthcare team, stick to your treatment plan and manage your condition with a number of features that can: • Help you learn about your condition and managing your current treatment • Track your disease activity to visualize any changes over time – and even share with your doctor • Help you keep track of your appointments at a glance The App is CE marked for conformance as a medical device.

  • 2.4
    out of 5
    38 Ratings

Added new features and improvements.

The developer, AbbVie, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Linked to You

    The following data may be collected and linked to your identity:

    • Health & Fitness
    • Contact Info
    • User Content
    • Identifiers
  • Data Not Linked to You

    The following data may be collected but it is not linked to your identity:

    • Usage Data
    • Sensitive Info
    • Diagnostics

Privacy practices may vary, for example, based on the features you use or your age. Learn More

The developer has not yet indicated which accessibility features this app supports. Learn More

  • Seller
    • AbbVie Inc
  • Size
    • 64.2 MB
  • Category
    • Medical
  • Compatibility
    Requires iOS 15.0 or later.
    • iPhone
      Requires iOS 15.0 or later.
    • iPod touch
      Requires iOS 15.0 or later.
    • Apple Vision
      Requires visionOS 1.0 or later.
  • Languages
    English and 6 more
    • English, Arabic, German, Portuguese, Romanian, Spanish, Traditional Chinese
  • Age Rating
    13+
    • 13+
    • Infrequent
      Medical Treatment information
  • Copyright
    • © 2023 AbbVie Inc.